May 25, 2022
According to the research report titled ‘Asia Pacific Clinical Trial Management System Market Forecast 2027 By End-use, By Component, By Product, By Delivery Mode, Research Report, Country Outlook, COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share’, available with MarketStudyReport, Asia Pacific clinical trial management system (CTMS) market size is expected to be worth over USD 425.6 million by 2027.
The surging prevalence of chronic diseases, rising innovation in digital technology, increasing research trials & funds availability, and advancements in mobile technology and cloud infrastructure are some of the major key factors driving the growth of the Asia Pacific clinical trial management system (CTMS) market.
Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4384879/
By component type, the services segment is expected to expand at 13.3% CAGR through 2027, on account of surging R&D expenditure as well as the adoption of robust solutions in clinical operations.
Moving on to delivery mode, the cloud-based segment is estimated to be valued at around USD 102.9 million by 2027, primarily attributable to rising demand for innovative drugs and devices along with increasing number of innovations to bolster accessibility and deployment across pharmaceuticals, biotechnical, and research organizations.
Citing the end-user landscape, clinical research organizations accounted for over 35.3% market share in 2020 and is projected to witness a stellar growth over the analysis period, ascribed to the soaring number of healthcare startups, investments, and government initiatives.
Regionally, China clinical trial management system industry is expected to observe a 13.2% CAGR through the forecast period, owing to rising participation in clinical trials by leading companies and favorable regulatory outlook.
Some of the major players operating in Asia Pacific clinical trial management system market are Merge Healthcare Inc., eResearch Technology Solutions, Oracle Corporation, Advarra Inc., Medidata Solution Inc., Veeva System Inc., and Paraxel International.